Adverse reaction to benzathine benzylpenicillin due to soy allergy: A case report by Barni, Simona et al.
JOURNAL OF MEDICAL
CASE REPORTS
Barni et al. Journal of Medical Case Reports  (2015) 9:134 
DOI 10.1186/s13256-015-0602-zCASE REPORT Open AccessAdverse reaction to benzathine
benzylpenicillin due to soy allergy:
a case report
Simona Barni1*, Francesca Mori1, Stefano Pantano2 and Elio Novembre1Abstract
Introduction: Soybean allergy is one of the most common food allergies especially among children. The Food
Allergen Labeling and Consumer Protection Act (FALCPA) in the US requires the labeling of soy lecithin because it
is derived from soybeans and may contain a number of IgE-binding proteins, possibly representing a source of
hidden allergens. Here we describe a pediatric case of soy allergy misunderstood as drug allergy.
Case presentation: An 11-year-old Caucasian girl was referred to our Allergy Unit because of the delayed
appearance of an itching papular rash at the site of an injection of benzathine benzylpenicillin delivered by prefilled
syringe. A skin test with benzathine benzylpenicillin and detection of serum-specific IgE to penicilloyl V, penicilloyl
G, ampicillin and amoxicillin were negative. From her past medical history we know that, at the age of three years,
she presented with edema of the lips and difficulty in breathing after eating a soy ice-cream. For that reason, she
underwent a skin prick test with soybean that was negative and a serum-specific IgE to soybean test that was
weakly positive (0.21KU/L). She underwent an oral provocation test with soy milk that yielded a positive result.
Conclusions: We describe a case of a patient with a delayed reaction to soy as a hidden allergen in a benzathine
benzylpenicillin prefilled syringe. This case shows that lecithin contaminated by soy proteins and used as an
excipient in drugs can cause reactions in patients with soy allergy. For that reason, the source of lecithin should
always be specified among the constituents of drugs to avoid a source of hidden allergens and difficulties in the
allergy work-up.
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Soybean allergy is one of the most common food allergies
especially among children. Approximately 0.4% of chil-
dren are allergic to soy but about half of them spontan-
eously recover by the age of 7 years [1].
Patients with soy allergy show a wide range of immuno-
globulin E (IgE) and non IgE-mediated clinical symptoms
[2]. For these reasons, the Food Allergen Labeling and
Consumer Protection Act (FALCPA) in the US, from
January 1, 2006, mandates labeling of all ingredients de-
rived from commonly allergenic foods, including soy-
beans, with the exception of highly refined oils [3]. The
FALCPA also requires the labeling of soy lecithin because
it is derived from soybeans and may contain a number of
IgE-binding proteins, possibly representing a source of* Correspondence: simonabarni@hotmail.com
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creativecommons.org/publicdomain/zero/1.0/hidden allergens [4]. Soy lecithin is not only used in the
food industry, as an antioxidant, but it is widely used in
topical skin care products, in various drugs administered
either topically, orally, intravenously or by inhalation, as
an emulsifier [5]. Here we describe a pediatric case of soy
allergy misunderstood as drug allergy.
Case presentation
An 11-year-old Caucasian girl was referred to our
Allergy Unit because of a delayed appearance (that is
after 12 hours) of an itching papular rash at the site of
an injection of benzathine benzylpenicillin 1,200,000 UI
(Biopharma, Rome, Italy) delivered via prefilled syringe
(Figure 1).
From the past medical history, at three years of age,
our patient had edema of the lips and difficulty in
breathing after eating a soy ice-cream. For that reason,
she underwent a blood test analysis to measure the level
of serum-specific IgE to milk, egg, soybean, tomato,cle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Figure 1 Skin reaction at the site of the benzathine benzylpenicillin
injection.
Table 1 Clinical findings
Race Caucasian
Sex female
Age 11 yrs
Respiratory allergy none
Food allergy soy
Past medical history splenectomized after an accident injury
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weakly positive (0.21 KUA/l) and she was put on a
soybean-free diet.
At nine years of age, because of a post-traumatic
spleen breakage, our patient was splenectomized and
from that moment she was put on antibiotic prophylaxis
with intramuscular benzathine benzylpenicillin (Biopharma)
every 21 days. Our patient tolerated 14 injections of the
drug in the formulation powder and using solvent for re-
constitution. On January 2012, because of the exit from
the market of this formulation, a new formulation, pack-
aged as a prefilled syringe, was used. After the first use,
our patient presented with a delayed papular rash at the
injection site, as mentioned above.
A skin prick test and intradermal test with benzylpeni-
cillin at a concentration of 10,000 UI and a patch test at
5% full-strength concentration were all negative. More-
over, the detection of serum-specific IgE to penicilloyl V,
penicilloyl G, ampicillin and amoxicillin was negative; a
skin prick test with soybean was negative and a serum-
specific IgE to soybean was weakly positive (0.21KUA/l).
Three months after the reaction mentioned above, and
after receiving informed consent from the girl and her
parents, we decided to perform an oral provocation test
(OPT) with cefpodoxime proxetil (200mg) that yielded a
negative result. We also performed an OPT with soymilk
(50ml divided into three doses) with no reaction after
two hours of observation on the first day; however, on the
second day, she presented with diarrhea and abdominalpain. We provide a summary of our patient’s clinical find-
ings (Table 1).
Taking into account the following factors: (a) the pres-
ence of soy lecithin among the constituents of benzathine
benzylpenicillin (Biopharma) both in the prefilled syringe
and in the formulation powder and solvent for reconstitu-
tion; and (b) the positive medical history for soy allergy, a
cause and effect link between soy lecithin and the allergic
reaction was suspected. Moreover, the positive OPT with
soymilk reinforced the hypothesis of a delayed allergy to
soy proteins contaminating the lecithin contained in the
prefilled syringe.
According to the current guidelines [6], we decided to
change the antibiotic prophylaxis to orally administered
cefpodoxime proxetil every 21 days and she had no fur-
ther reactions.
Discussion
We describe a case of a patient with a delayed reaction
to soy as an hidden allergen in a benzathine benzylpeni-
cillin prefilled syringe.
Allergic reactions to soy lecithin have been previously
reported in the literature: occupational asthma in bakers
[7], chronic diarrhea in a child [8], and anaphylactic re-
action in a 40-year-old woman treated with an inhalatory
drug [9].
We hypothesized that beside the history of immediate
IgE-mediated systemic reaction to soy, the skin reaction
under investigation was not due to an IgE-mediated
mechanism, considering the low level of specific IgE to
soy and the delayed onset of her symptoms, but most
likely it could be due to a cell-mediated reaction, as con-
firmed by the OPT.
Gu et al. [4] demonstrated that soy lecithin contains a
number of IgE-binding proteins thus it might represent
a source of hidden allergens. The presence of these al-
lergens is a most significant concern for soy-allergic
individuals consuming lecithin products as a health
supplement. Presently, lecithin products used as health
supplements are not labeled as containing soy protein.
Although both formulations contain soy lecithin, we
hypothesized that the reasons why our patient only
reacted to the prefilled syringe were: (a) a different
purification of lecithin extracted from soy, and (b) a
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the antibiotic therapy.
Conclusions
This case shows that lecithin contaminated by soy pro-
teins and used as an excipient in drugs can cause reac-
tions in patients with soy allergy. For that reason, the
source of lecithin should always be specified among the
constituents of drugs and on the labels of food products
to avoid a source of hidden allergens and difficulties in
the allergy work-up.
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